Older adults with cancer and clinical decision-making: The importance of assessing cognition

Wee Kheng Soo

Research output: Contribution to journalReview ArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Cognitive impairment presents unique clinical challenges in the management of older adults with cancer. With an ageing population, the recognition and management of cognitive impairment is likely to become more important in oncology practice. Currently, screening for cognitive impairment is not routinely performed in oncology. However, screening has been shown to detect cognitive deficits in a significant proportion of older adults with cancer. This can have a significant impact on treatment decisions, including determining suitability for cancer therapy and capacity to provide informed consent. In addition, cognitive impairment can enhance the risk of complications from cancer and its treatment. Early identification can facilitate appropriate decision-making and interventions to minimise its consequences. Further research is needed on recognition and management of cognitive impairment in older adults with cancer. This article provides an overview of cognitive impairment in older adults with cancer, with the aim of informing clinicians on the importance of assessing cognition.

Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalCancer Forum
Volume37
Issue number3
Publication statusPublished - Nov 2013
Externally publishedYes

Cite this